TUM – Technical University of Munich Menu
Die Abbildung zeigt einen histologischen Gewebeschnitt einer Steatoheaptitis im Menschen. (Bild: A. Weber / Universitätsspital Zürich, Erklärung s. unten)
Die Abbildung zeigt einen histologischen Gewebeschnitt einer Steatoheaptitis im Menschen. (Bild: A. Weber / Universitätsspital Zürich, Erklärung s. unten)
  • Research news

Clarifying molecular mechanisms for common liver diseases

Immune cells in the liver drive fatty liver disease and liver cancer

Immune cells that migrate to the liver and interact there with liver tissue cells get activated by metabolic stress (e.g. through lipids of a high fat diet) and drive the development of fatty liver disease, non-alcoholic steatohepatitis and liver cancer. Scientists from the Technische Universität München (TUM), the Helmholtz Zentrum München and the Zurich University Hospital made this discovery in an animal model and in patients and thus identified the previously unknown mechanism underlying these serious and widespread diseases. The results of their research have been published as the cover story of the journal Cancer Cell.

Fatty liver disease – alongside fatty liver due to massive alcohol consumption – is mainly caused by excessive consumption of fat and sugar combined with a lack of exercise or a sedentary life style. This is referred to as non-alcoholic fatty liver disease (NAFLD). If NAFLD becomes chronic – e.g. through the constant uptake of high lipids and high sugar combined with lack of exercise a chronic inflammatory response is triggered in the liver tissue in addition. This can lead to non-alcoholic steatohepatitis (NASH) – a liver disease with clear detectable pathologic alterations of the tissue. These liver diseases (NAFLD and NASH), along with chronic viral infections, are the most common causes of liver cancer, or hepatocellular carcinoma (HCC).

In the United States, about 90 million people suffer from NAFLD. In Europe, the figure is more than 40 million, and even in threshold countries like India and China, the number of people affected is rising due to increasingly unhealthy lifestyles. More worrying, in all of the above mentioned states the numbers of NAFLD and NASH patients is constantly increasing. Consequently, the incidence of HCC resulting from NASH and NAFLD is also rising worldwide. In the United States, HCC is the fastest-growing form of cancer at the moment. No efficient causal therapy exists for HCC patients of which approximately 800.000 die every year.

T cells involved in the development of fatty liver disease, NASH and HCC

The mechanisms that cause diseases such as fatty liver disease, steatohepatitis and HCC are still not widely understood. However, immune cells, particularly CD8+ T cells and NK T cells seem to play an important role. This finding was made by a team of scientists led by Prof. Mathias Heikenwälder from the Institute of Virology, together with Prof. Percy Knolle of the Technische Universität München (TUM) and colleagues of the group of Prof. Matthias Tschöp and Dr. Kristian Unger from the Helmholtz Zentrum München together with Prof. Achim Weber and Dr. Monika Wolf from Zurich University Hospital.

The animal model which was used to examine the long-term effects of metabolic syndrome enabled the scientists to elucidate new mechanisms that cause fatty liver disease and also show how it can develop into liver cancer. It also represents human pathology. The metabolic syndrome is a combination of obesity/abdominal adiposity, insulin resistance, raise levels of lipids in the blood and raised blood pressure.

Inflammatory events offer starting point for prevention and treatment

The scientists assume that an existing metabolic imbalance results in the activation and migration of immune cells to the liver. There, the immune cells interact with liver cells and trigger an inflammatory response that damages the liver tissue and also destabilizes the metabolic activity of the liver cells.

“Initially it immune cells promote fatty liver degeneration. The inflammation, which is triggered by specific immune cells, encourages the progression of fatty liver pathology and causes NASH to develop. These processes are the basis for liver cell degeneration, which can cause HCC,” explains Prof. Heikenwälder, who led the study. “Our results provide completely new insights into the development of these serious liver diseases. Building on this knowledge, we already develop new, preventive and therapeutic strategies to combat these diseases.” The initial studies are already under way in the preclinical model.


Original publication
Wolf M. J., Adili A., Piotrowitz K., Abdullah Z., Boege Y., Stemmer K., Ringelhan M., Simonavicius N., Egger M., Wohlleber D., Lorentzen A., Einer C., Schulz S., Clavel T., Protzer U., Thiele C., Zischka H., Moch H., Tschöp M., Tumanov A. V., Haller D., Unger K., Karin M., Kopf M., Knolle P., Weber A. and Heikenwalder M., Metabolic activation of intrahepatic CD8+ and NKT-cells causes nonalcoholic steatohepatitis and hepatocellular carcinoma via cross-talk with hepatocytes, Cancer Cell, 2014.
DOI: 10.1016/j.ccell.2014.09.003

Contact
Prof. Dr. Mathias Heikenwälder
Helmholtz Zentrum München/Technische Universität München
Institute of Virology
Phone: +49 89 4140-7440
heikenwaelder(at)helmholtz-muenchen.de 
www.virologie.med.tu-muenchen.de/en


Further information

Corporate Communications Center

Technical University of Munich Dr. Nadja Becker (HMGU) / Dr. Vera Siegler
vera.siegler(at)tum.de

Article at tum.de

Percy Knolle, Professor für Molekulare Immunologie an der TUM, untersucht die Ursachen des Leberversagens. (Bild: A. Heddergott / TUM)

Liver failure caused by attack on blood vessel cells

In severe cases, a viral hepatitis infection can result in liver failure. A team from the Technical University of Munich (TUM) has now discovered how this occurs: by immune cells attacking cells in the vascular system,...

Prof. Jürgen Ruland (rechts) und Dr. Tim Wartewig haben mit ihrer neuen Studie einen neuen Ansatzpunkt für Therapien gegen Lymphdrüsenkrebs gefunden. (Bild: A. Heddergott / TUM)

Shut-off switch for lymphoma

A safety switch that automatically stops the device for example before it overheats are built into many electrical appliances. The body's cells are also equipped with this kind of "emergency stop" functions. They make sure...

Die Leber - ein lebenswichtiges Organ. (Foto: Fotolia / PIC4U)

How bile duct cancer develops and how it can be prevented

What promotes the development of bile duct cancer in the liver? Are these factors different from those that are responsible for the much more common hepatocellular carcinomas? Scientists from the German Cancer Research...

MGCs und Fresszellen (Makrophagen) wurden mit Membran-spezifischen (grau) und Zellkern-spezifischen (blau) Farbstoffen gefärbt. Auf dem Bild sind zwei Riesenzellen zu sehen (Mitte und unten links), die von einigen kleineren, einkernigen Fresszellen umgeben sind. (Bild: Ronny Milde / TUM)

Giant waste bins

If rubbish is too big and unwieldy for normal household waste, its removal becomes the job of specialized experts. Researchers from the Technical University of Munich (TUM) have now discovered, in cooperation with...

Prof. Percy Knolle (Mitte) sucht mit seinem Team am Institut für Molekulare Immunologie unter anderem nach neuen Mechanismen der Immundiagnostik. (Bild: A. Heddergott / TUM)

Cell marker enables prognosis about the course of infections

When a pathogen invades the body, specific cells in the human immune system are ready to take immediate action in order to destroy it. The molecular characteristics of these killer cells were unknown until recently. Now,...

Die fluoreszenzmikroskopische Aufnahme zeigt die Ubiquitin-Ligase FBXO25 (grün) und das überlebenssichernde Protein (rot) in einer Krebszelle, die gerade den Zelltod einleitet. Das gelbe Signal zeigt an, wenn beide Proteine am selben Ort sind. (Bild: F. Bassermann / TUM)

Mutations prevent programmed cell death

Programmed cell death is a mechanism that causes defective and potentially harmful cells to destroy themselves. It serves a number of purposes in the body, including the prevention of malignant tumor growth. Now,...

Prof. Jürgen Ruland (rechts) erforscht mit seiner Arbeitsgruppe unter anderem die Entstehung und Bekämpfung von Lymphomen. (Bild: A. Heddergott / TUM)

Side effects of possible anti-cancer strategy discovered

The Malt1 protein is one of the most important control centers in human immune cells and a real all-rounder. Genetic defects in it can lead to the development of lymphatic cancer (lymphoma). A possible therapeutic approach...

Prof. Percy Knolle (rechts) erforscht mit seiner Arbeitsgruppe unter anderem die Regulation von Immunantworten in der Leber. (Bild: A. Heddergott / TUM)

Synthetic messenger boosts immune system

Specific immune cells, known as T lymphocytes, have to be activated so that the body can develop long-term protection against infections. Previously, it was believed that this process only took place in the lymph nodes and...

Prof. Ulrike Protzer und Dr. Felix Bohne überprüfen die Blutproben-Ergebnisse von HCV-infizierten Leberempfängern. (Bild: E. Mitterwallner / TUM)

Virus infection supports organ acceptance

Chronic hepatitis C virus infections are among the most common reasons for liver transplants. Because existing viruses also infect the new liver, the immune system is highly active there. Despite this, the new organ is not...